home All News open_in_new Full Article

With China approval, Lilly and Innovent's mazdutide breaks into new class for GLP

With China approval, Lilly and Innovent's mazdutide breaks into new class for GLP-1 obesity drugs  Fierce Pharma


today 4 d. ago attach_file Politics

attach_file Transport
attach_file Science
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Politics
attach_file Events
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics


ID: 2421236139
Add Watch Country

arrow_drop_down